Singulex, Inc. Release: New Data From TIMI Study Group to be Presented at American College of Cardiology Scientific Session Show Prognostic Value of High-Precision Cardiac Troponin Monitoring
3/8/2013 10:31:54 AM
More...
|
Singulex, Inc. Files for a $86 Million IPO
10/1/2012 8:26:32 AM
More...
|
Singulex, Inc. to Host User Meeting for Erenna® Immunoassay Technology: Participation Details
2/21/2012 9:10:52 AM
More...
|
Singulex, Inc. Announces Issuance of U.S. Patents for Single Molecule Detection of Protein Biomarkers and Key Biomarker for Cardiac Risk Monitoring
12/14/2010 9:34:05 AM
More...
|
Singulex, Inc. Closes $19 Million Financing Round
1/12/2009 6:37:22 AM
More...
|
Singulex, Inc. to Develop Assays to Assess Efficacy of Cancer Therapeutics
7/29/2008 7:38:32 AM
More...
|
Singulex, Inc. Advances Conversation on Personalized Medicine
5/13/2008 3:37:06 PM
More...
|
Singulex, Inc. Collaborates With Large Pharmaceutical Company in Erenna(TM) Technology Access Program Opens Facility to Support European Partnerships
3/6/2008 7:54:58 AM
More...
|
Singulex, Inc. Teams With Wyeth (WYE) to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
11/27/2007 7:11:12 AM
More...
|
Singulex, Inc. Collaborates With Washington University School of Medicine
11/15/2007 7:32:13 AM
More...
|
|